Manipulation of the microbiota for treatment of IBS and IBD - Challenges and controversies

Gastroenterology

Volumn 146, Issue 6, 2014, Pages 1554-1563

  Shanahan, Fergus ^a,b   Quigley, Eamonn M M ^a,c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c Division of Gastroenterology and Hepatology   (United States)

Author keywords

Fecal Transplantation; Pharmabiotic; Prebiotic; Probiotic

Indexed keywords

ANTIBIOTIC AGENT; PROBIOTIC AGENT; RIFAXIMIN;

ARTICLE; BACTERIAL OVERGROWTH; BEHAVIOR CHANGE; BRAIN DEVELOPMENT; COLON CARCINOGENESIS; CONSUMER; CROHN DISEASE; DIGESTIVE SYSTEM FUNCTION DISORDER; DYSPEPSIA; ENVIRONMENTAL FACTOR; FOOD INDUSTRY; GENETIC SUSCEPTIBILITY; HEALTH DISPARITY; HUMAN; IMMUNE RESPONSE; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; IRRITABLE COLON; MATERNAL DEPRIVATION; MICROBIAL COLONIZATION; NONHUMAN; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; RISK FACTOR; STOMACH ACID SECRETION; STRESS; TISSUE INJURY; TREATMENT RESPONSE; ULCERATIVE COLITIS; VIRAL GASTROENTERITIS;

FECAL TRANSPLANTATION; PHARMABIOTIC; PREBIOTIC; PROBIOTIC;

ANIMALS; BIOLOGICAL THERAPY; DYSBIOSIS; FECES; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; IRRITABLE BOWEL SYNDROME; MICROBIOTA; PREBIOTICS; PROBIOTICS; TREATMENT OUTCOME;

EID: 84898835480     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.01.050     Document Type: Article

References (66)

1. F. Shanahan The gut microbiota-a clinical perspective on lessons learned Nat Rev Gastroenterol Hepatol 9 2012 609 614
2. B.D. Wallace, H. Wang, and K.T. Lane et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme Science 330 2010 831 835
3. F. Shanahan Probiotics in perspective Gastroenterology 139 2010 1808 1812
4. F. Shanahan, T.G. Dinan, and P. Ross et al. Probiotics in transition Clin Gastroenterol Hepatol 10 2012 1220 1224
5. F. Shanahan The microbiota in inflammatory bowel disease: friend, bystander, and sometime-villain Nutr Rev 70 Suppl 1 2012 S31 S37
6. G.A. Preidis, and J. Versalovic Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era Gastroenterology 136 2009 2015 2031
7. P. Moayyedi, A.C. Ford, and N.J. Talley et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review Gut 59 2010 325 332
8. S. Nikfar, R. Rahimi, and F. Rahimi et al. Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials Dis Colon Rectum 51 2008 1775 1780
9. L.V. McFarland, and S. Dublin Meta-analysis of probiotics for the treatment of irritable bowel syndrome World J Gastroenterol 14 2008 2650 2661
10. D.M. Brenner, M.J. Moeller, and W.D. Chey et al. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review Am J Gastroenterol 104 2009 1033 1049
11. V.E. Rolfe, P.J. Fortun, and C.J. Hawkey et al. Probiotics for maintenance of remission in Crohn's disease Cochrane Database Syst Rev 4 2006 CD004826
12. R. Rahimi, S. Nikfar, and F. Rahimi et al. A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease Dig Dis Sci 53 2008 2524 2531
13. J. Shen, H.Z. Ran, and M.H. Yin et al. Meta-analysis: the effect and adverse events of Lactobacilli versus placebo in maintenance therapy for Crohn disease Intern Med J 39 2009 103 109
14. G. Doherty, G. Bennett, and S. Patil et al. Interventions for prevention of post-operative recurrence of Crohn's disease Cochrane Database Syst Rev 4 2009 CD006873
15. G.A. Doherty, G.C. Bennett, and A.S. Cheifetz et al. Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn's disease Aliment Pharmacol Ther 31 2010 802 809
16. L.X. Sang, B. Chang, and W.L. Zhang et al. Remission induction and maintenance effect of probiotics on ulcerative colitis: a meta-analysis World J Gastroenterol 16 2010 1908 1915
17. K. Naidoo, M. Gordon, and A.O. Fagbemi et al. Probiotics for maintenance of remission in ulcerative colitis Cochrane Database Syst Rev 12 2011 CD007443
18. Orwell G. Politics of the English language. 1946. Available at: http://www.npr.org/blogs/ombudsman/Politics-and-the-English-Language-1.pdf. Accessed Dec 17, 2013.
19. FAO/WHO Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria 2001 World Health Organization Basel, Switzerland
20. K. Cadwell, K.K. Patel, and N.S. Maloney et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine Cell 141 2010 1135 1145
21. T.H. Hand, L.M. Dos Santos, and N. Bouladoux et al. Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses Science 337 2012 1553 1556
22. C. Bothin, and T. Midtvedt The role of gastrointestinal microflora in postsurgical adhesion formation-a study in germfree rats Eur Surg Res 24 1992 309 312
23. M. Mourelle, A. Salas, and F. Guarner et al. Stimulation of transforming growth factor beta1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis Gastroenterology 114 1998 519 526
24. E.A.F. Van Tol, L. Holt, and F. Ling Li et al. Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts Am J Physiol 277 1999 G245 G255
25. R.J. Rigby, M.R. Hunt, and B.P. Scull et al. A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora Gut 58 2009 1104 1112
26. F. Shanahan The colonic microbiota in health and disease Curr Opin Gastroenterol 29 2013 49 54
27. W.E. Whitehead, B.T. Engel, and M.M. Schuster Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients Dig Dis Sci 25 1980 404 413
28. G.F. Longstreth, W.G. Thompson, and W.D. Chey et al. Functional bowel disorders Gastroenterology 130 2006 1480 1491
29. E.M. Quigley Bugs on the brain; brain in the gut-seeking explanations for common gastrointestinal symptoms Ir J Med Sci 182 2012 1 6
30. E.M. Quigley Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management J Dig Dis 8 2007 2 7
31. H. Suzuki, and P. Moayyedi Helicobacter pylori infection in functional dyspepsia Nat Rev Gastroenterol Hepatol 10 2013 168 174
32. A.A. Villarreal, F.J. Aberger, and R. Benrud et al. Use of broad-spectrum antibiotics and the development of irritable bowel syndrome WMJ 111 2012 17 20
33. M. Pimentel, E.J. Chow, and H.C. Lin Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome Am J Gastroenterol 95 2000 3503 3506
34. I.B. Jeffery, E.M. Quigley, and L. Ohman et al. The microbiota link to irritable bowel syndrome: an emerging story Gut Microbes 3 2012 572 576
35. I.M. Carroll, T. Ringel-Kulka, and T.O. Keku et al. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome Am J Physiol Gastrointest Liver Physiol 301 2011 G799 G807
36. I.B. Jeffery, P.W. O'Toole, and L. Öhman et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota Gut 61 2012 997 1006
37. H. Duboc, D. Rainteau, and S. Rajca et al. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome Neurogastroenterol Motil 24 2012 513 520 e246-e247
38. C. Manichanh, A. Eck, and E. Varela et al. Anal gas evacuation and colonic microbiota in patients with flatulence: effect of diet Gut 63 2014 401 408
39. G.T. Macfarlane, and S. Macfarlane Bacteria, colonic fermentation, and gastrointestinal health J AOAC Int 95 2012 50 60
40. E.M.M. Quigley Therapies aimed at the gut microbiota and inflammation. Antibiotics, probiotics/prebiotics/synbiotics, anti-inflammatory therapies Gastroenterol Clin North Am 40 2011 207 222
41. M. Pimentel, A. Lembo, and W.D. Chey et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation N Engl J Med 364 2011 22 32
42. J.F. Cryan, and S.M. O'Mahony The microbiome-gut-brain axis: from bowel to behavior Neurogastroenterol Motil 23 2011 187 192
43. A. Hviid, H. Svanström, and M. Frisch Antibiotic use in inflammatory bowel diseases in childhood Gut 60 2011 49 54
44. S.Y. Shaw, J.F. Blanchard, and C.N. Bernstein Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease Am J Gastroenterol 105 2010 2687 2692
45. S.M. Collins The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders Gastroenterology 111 1996 1683 1699
46. G. Barbara, V. Stanghellini, and G. Brandi et al. Interactions between commensal gut flora and gut sensorimotor function in health and disease Am J Gastroenterol 100 2005 2560 2568
47. A. Agrawal, L.A. Houghton, and J. Morris et al. Clinical trial: the effects of a fermented milk product containing bifidobacteriumlactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation Aliment Pharmacol Ther 29 2009 104 114
48. H.J. Kim, M. Camilleri, and S. McKinzie et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea- predominant irritable bowel syndrome Aliment Pharmacol Ther 17 2003 895 904
49. H.J. Kim, M.I. Vazquez Roque, and M. Camilleri et al. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating Neurogastroenterol Motil 17 2005 687 696
50. K. Tillisch, J. Labus, and L. Kilpatrick et al. Consumption of fermented milk product with probiotic modulates brain activity Gastroenterology 144 2013 1394 1401
51. D. Groeger, L. O'Mahoney, and E.F. Murphy et al. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut Gut Microbes 4 2013 325 339
52. W.I. Khan, and S.M. Collins Gut motor inflammation: immunological control in enteric infection and inflammation Clin Exp Immunol 143 2005 389 397
53. C.M. Thomas, and J. Versalovic Probiotics-host communication: modulation of signaling pathways in the intestine Gut Microbes 1 2010 148 163
54. S.M. O'Mahony, J.R. Marchesi, and P. Scully et al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses Biol Psychiatry 65 2009 263 267
55. S.M. O'Mahony, H.M. Savignac, and T. O'Brien et al. Early-life dysbiosis-induced visceral hypersensitivity in adulthood Gastroenterology 138 2010 S4 S5
56. R. Spiller, and C. Lam An update on post-infectious irritable bowel syndrome: role of genetics, immune activation, serotonin and altered microbiome J Neurogastroenterol Motil 18 2012 258 268
57. E.M. Quigley, and B. Flourie Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date Neurogastroenterol Motil 19 2007 166 172
58. E.M.M. Quigley Probiotics in gastrointestinal disorders Hosp Pract 38 2010 122 129
59. A. Andriulli, M. Neri, and C. Loguercio et al. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study J Clin Gastroenterol 42 Suppl 3 2008 S218 S223
60. F. Shanahan A commentary on the safety of probiotics Gastroenterol Clin North Am 41 2012 869 876
61. J.L. Anderson, R.J. Edney, and K. Whelan Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease Aliment Pharmacol Ther 36 2012 503 516
62. C.J. Damman, S.I. Miller, and C.M. Surawicz et al. The microbiome and inflammatory bowel disease: is there a role for fecal microbiota transplantation? Am J Gastroenterol 107 2012 1452 1459
63. L.J. Brandt, and O.C. Aroniadis An overview of fecal microbiota transplantation: techniques, indications, and outcomes Gastrointest Endosc 78 2013 240 249
64. F. Shanahan Gut microbes: from bugs to drugs Am J Gastroenterol 105 2012 275 279
65. S.K. Kuss, G.T. Best, and C.A. Etheredge et al. Intestinal microbiota promote enteric virus replication and systemic pathogenesis Science 334 2011 249 252
66. H.V. Virgin, and J.A. Todd Metagenomics and personalized medicine Cell 147 2011 44 56